HealthEquity, Inc. (NASDAQ:HQY) Receives Average Recommendation of "Moderate Buy" from Analysts

Key Points

• HealthEquity, Inc. has been given an average recommendation of "Moderate Buy" by fourteen analysts, with eleven analysts assigning a buy rating and one a strong buy rating.
• The average 12-month price target for HealthEquity shares is approximately $119.77 based on recent analyst reports.
• Insiders own 1.50% of HealthEquity’s stock, with the recent sale of shares by Executive Vice President Delano Ladd indicating a 7.02% decrease in his ownership.

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) has received an average recommendation of "Moderate Buy" from the fourteen analysts that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $119.7692.

A number of equities research analysts recently weighed in on HQY shares. JPMorgan Chase & Co. boosted their price objective on HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 3rd. Weiss Ratings restated a "hold (c+)" rating on shares of HealthEquity in a report on Saturday, September 27th. Barrington Research reiterated an "outperform" rating and issued a $125.00 price objective on shares of HealthEquity in a report on Friday, August 29th. Raymond James Financial reiterated a "strong-buy" rating and set a $120.00 target price (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Finally, Jefferies Financial Group upped their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a research report on Wednesday, September 3rd.

HealthEquity Stock Performance

NASDAQ HQY opened at $87.78 on Tuesday. The firm's fifty day moving average price is $91.99 and its two-hundred day moving average price is $93.87. The stock has a market cap of $7.56 billion, a PE ratio of 53.20, a PEG ratio of 1.27 and a beta of 0.47. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. HealthEquity has a fifty-two week low of $74.07 and a fifty-two week high of $116.65.

Insiders Place Their Bets

In related news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction on Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the completion of the sale, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.50% of the stock is owned by insiders.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Nisa Investment Advisors LLC boosted its position in HealthEquity by 2.9% during the second quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company's stock valued at $397,000 after acquiring an additional 108 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in shares of HealthEquity by 4.7% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company's stock valued at $255,000 after purchasing an additional 110 shares during the period. Ieq Capital LLC boosted its position in shares of HealthEquity by 4.4% during the 1st quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock valued at $260,000 after purchasing an additional 123 shares in the last quarter. Xponance Inc. grew its stake in HealthEquity by 1.1% during the first quarter. Xponance Inc. now owns 12,412 shares of the company's stock worth $1,097,000 after purchasing an additional 136 shares during the period. Finally, Coldstream Capital Management Inc. increased its holdings in HealthEquity by 7.3% in the second quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company's stock worth $212,000 after purchasing an additional 138 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.